129 related articles for article (PubMed ID: 8335832)
1. Plasma atrial natriuretic peptide response to direct current cardioversion of atrial fibrillation in patients with mitral stenosis.
Fujiwara H; Ishikura F; Nagata S; Beppu S; Miyatake K
J Am Coll Cardiol; 1993 Aug; 22(2):575-80. PubMed ID: 8335832
[TBL] [Abstract][Full Text] [Related]
2. Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
J Am Coll Cardiol; 2003 May; 41(10):1716-20. PubMed ID: 12767653
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide in atrial fibrillation before and after electrical cardioversion therapy.
Petersen P; Kastrup J; Vilhelmsen R; Schütten HJ
Eur Heart J; 1988 Jun; 9(6):639-41. PubMed ID: 2970387
[TBL] [Abstract][Full Text] [Related]
4. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
Bakowski D; Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
[TBL] [Abstract][Full Text] [Related]
5. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
[TBL] [Abstract][Full Text] [Related]
6. Time to recover from atrial hormonal, mechanical, and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation.
Nishino M; Hoshida S; Tanouchi J; Ito T; Kato J; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
Am J Cardiol; 2000 Jun; 85(12):1451-4. PubMed ID: 10856391
[TBL] [Abstract][Full Text] [Related]
7. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
Wozakowska-Kapłon B; Opolski G
Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
[TBL] [Abstract][Full Text] [Related]
8. Clinical, adrenergic and heart endocrine measures in chronic atrial fibrillation as predictors of conversion and maintenance of sinus rhythm after direct current cardioversion.
Theodorakis GN; Markianos M; Kouroubetsis CK; Livanis EG; Paraskevaidis IA; Kremastinos DT
Eur Heart J; 1996 Apr; 17(4):550-6. PubMed ID: 8733088
[TBL] [Abstract][Full Text] [Related]
9. Alternations in atrial natriuretic peptide release after DC cardioversion of non-valvular chronic atrial fibrillation.
Arakawa M; Miwa H; Noda T; Ito Y; Kambara K; Kagawa K; Nishigaki K; Kano A; Hirakawa S
Eur Heart J; 1995 Jul; 16(7):977-85. PubMed ID: 7498215
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation.
Wozakowska-Kaplon B; Opolski G
Int J Cardiol; 2002 May; 83(2):159-65. PubMed ID: 12007688
[TBL] [Abstract][Full Text] [Related]
11. Plasma atrial natriuretic peptide levels for predicting the outcome of atrial fibrillation.
Arad M; Shotan A; Weinberger A; Aurbach I; Rabinowitz B
Cardiology; 2001; 95(2):74-9. PubMed ID: 11423710
[TBL] [Abstract][Full Text] [Related]
12. Restoration of mechanical atrial function after electrical cardioversion of chronic atrial fibrillation in patients after surgical treatment of mitral valve disease--hemodynamic effects and prognostic value of maintenance of sinus rhythm.
Szyszka A; Trojnarska O; Paluszkiewicz L; Cieśliński A; Ponizyński A
Cardiology; 1996; 87(2):98-103. PubMed ID: 8653737
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm.
Beck-da-Silva L; de Bold A; Fraser M; Williams K; Haddad H
Can J Cardiol; 2004 Oct; 20(12):1245-8. PubMed ID: 15494777
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide response to cardioversion of atrial flutter and fibrillation and role of associated heart failure.
Mookherjee S; Anderson G; Smulyan H; Vardan S
Am J Cardiol; 1991 Feb; 67(5):377-80. PubMed ID: 1825258
[TBL] [Abstract][Full Text] [Related]
15. [The influence of electrical cardioversion on left ventricular systolic function, left atrial size, ANP levels and enzymatic activity of CPK and CD-MB in serum of patients with paroxysmal atrial fibrillation].
Spring A; Kosmala W; Mysiak A
Przegl Lek; 1997; 54(9):585-90. PubMed ID: 9501676
[TBL] [Abstract][Full Text] [Related]
16. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation.
Ohta Y; Shimada T; Yoshitomi H; Inoue S; Murakami Y; Shimizu H; Nakamura K; Ohta T; Katoh H; Ishibashi Y
Can J Cardiol; 2001 Apr; 17(4):415-20. PubMed ID: 11329541
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
Wozakowska-Kapłon B; Opolski G; Janion M
Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion.
Shin DI; Jaekel K; Schley P; Sause A; Müller M; Fueth R; Scheffold T; Guelker H; Horlitz M
Z Kardiol; 2005 Dec; 94(12):795-800. PubMed ID: 16382379
[TBL] [Abstract][Full Text] [Related]
19. Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease.
Gosselink AT; Crijns HJ; Hamer HP; Hillege H; Lie KI
J Am Coll Cardiol; 1993 Nov; 22(6):1666-72. PubMed ID: 8227836
[TBL] [Abstract][Full Text] [Related]
20. An increase in plasma atrial natriuretic peptide concentration during exercise predicts a successful cardioversion and maintenance of sinus rhythm in patients with chronic atrial fibrillation.
Wozakowska-Kaplon B; Opolski G; Kosior D; Janion M
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1876-9. PubMed ID: 11139947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
